We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Low Success Rate for Phase II Trials Cause for Concern, Study Says
Low Success Rate for Phase II Trials Cause for Concern, Study Says
May 25, 2011
Decreasing success rates for Phase II drug candidates are cause for concern, as the overall attrition of late-stage drug development “seems to be unsustainability high,” a new Centre for Medicines Research (CMR) analysis says.